The review pursuant to Article 5.1.1.1 of the International Standard  for Results Management  of an Adverse Analytical Finding ,       WT 2021 Anti-Doping Rules  17  reported shortly after the TUE expiry, withdrawal or r eversal,  shall include consideration of whether such finding is consistent with Use of the Prohibited Substance  or Prohibited Method prior to that date, in which event no anti -doping rule violation shall be asserted.